STERIS plc

Company facts

Industry

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Headquarters

Dublin

Most recent report

10-Q, filed Aug 7, 2026

Filings on record

678 filings

On EDGAR

CIK 1757898

Fiscal year ends

March

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 2 of 10 sections worth reading, with 3 positive, 2 notable, and 2 negative flags.

• Item 1

  Core financials with Q1 results, new buyback, restructuring, and litigation update.
  Positive

  • New $1B buyback program authorized on May 5, 2026, replacing $500M program with $150M remaining.
  Notable

  • Illinois EO litigation settlement nearly done: payments made, claims dismissed with prejudice.
  • Post-quarter restructuring plan announced August 2026, expects $55–70M in charges through fiscal 2030.
  Negative

  • Effective income tax rate rose from 23.3% to 26.5% due to unfavorable discrete items.

• Item 2

  Full of results, segment data, new restructuring plan, and buyback activity.
  Positive

  • Revenue up 7.3% to $1,492.7M in Q1 2027, driven by volume and pricing across segments.
  • Board adopted a new share repurchase program on May 5, 2026; $100M bought in Q1 2027.
  Negative

  • Free cash flow dropped to $279.6M from $326.5M in Q1 2027 due to lower working capital contribution.

What changed: Jun 2026 vs. Dec 2025

About 11% of STE's Jun 2026 10-Q is new information. 34 paragraphs were added, 178 changed, and 99 removed. Below are the most important lines SECSift identified.

• Item 2 91
• Item 1 80
• Item 3 4
• Item 4 1
• Item 1A 1
• Item 5 1